Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Income from Continuing Operations: 2022-2025

Historic Income from Continuing Operations for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$48.2 million.

  • Gossamer Bio's Income from Continuing Operations fell 56.55% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$157.2 million, marking a year-over-year increase of 5.12%. This contributed to the annual value of -$56.5 million for FY2024, which is 68.56% up from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's Income from Continuing Operations is -$48.2 million, which was down 31.61% from -$36.6 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Income from Continuing Operations ranged from a high of -$30.8 million in Q3 2024 and a low of -$59.0 million during Q3 2022.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$41.9 million (2024), whereas its average is -$42.1 million.
  • As far as peak fluctuations go, Gossamer Bio's Income from Continuing Operations skyrocketed by 32.23% in 2023, and later crashed by 56.55% in 2025.
  • Quarterly analysis of 4 years shows Gossamer Bio's Income from Continuing Operations stood at -$57.2 million in 2022, then grew by 15.85% to -$48.1 million in 2023, then surged by 31.40% to -$33.0 million in 2024, then tumbled by 56.55% to -$48.2 million in 2025.
  • Its Income from Continuing Operations stands at -$48.2 million for Q3 2025, versus -$36.6 million for Q2 2025 and -$39.3 million for Q1 2025.